World News: 22:05 GMT Monday 16th April 2018. [AstraZeneca via Globe Newswire via SPi World News]
CAMBRIDGE United Kingdom, April 16 2018 GLOBE NEWSWIRE -- AstraZeneca and MedImmune its global biologics research and development arm today presented efficacy and safety data from two Phase I trials evaluating durvalumab in combination wit h treme...
Globe Newswire: 22:05 GMT Monday 16th April 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.